AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Dolutegravir Sodium in South Africa

9 products registered with SAHPRA 7 active

Brand / ProductReg. No.HolderStatusExpires
VULANTE53/20.2.8/0082Pharmacare Limited û Woodmeadactive9 Oct 2029
DOLUTEGRAVIR CIPLA 5051/20.2.8/1031Cipla Medpro Manufacturing (Pty) Ltdactive15 May 2024
DALIMUNE51/20.2.8/1032.1031Cipla Medpro Manufacturing (Pty) Ltdactive15 May 2024
TRIDOZIA53/20.2.8/0087Pharmacare Limited û Woodmeadsuspended31 Oct 2023
TENOLAM PLUS53/20.2.8/0088.087Pharmacare Limited û Woodmeadsuspended31 Oct 2023
DALIDUO55/20.2.8/0301Cipla Medpro Manufacturing (Pty) Ltdactive1 Jan 1900
DALIVINE55/20.2.8/0302.301Cipla Medpro Manufacturing (Pty) Ltdactive1 Jan 1900
LOMIDA54/20.2.8/0642.641Cipla Medpro Manufacturing (Pty) Ltdactive1 Jan 1900
DALVUTIN54/20.2.8/0641Cipla Medpro Manufacturing (Pty) Ltdactive1 Jan 1900

Dolutegravir SodiumSAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Dolutegravir Sodium, of which 7 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Dolutegravir Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.